Trial record 1 of 25 for:    psk seattle
Previous Study | Return to List | Next Study

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

This study has been withdrawn prior to enrollment.
(funding sequestered)
Sponsor:
Collaborators:
University of Washington
Fred Hutchinson Cancer Research Center
Information provided by (Responsible Party):
Bastyr University
ClinicalTrials.gov Identifier:
NCT01685489
First received: September 6, 2012
Last updated: October 23, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given